As Ebola rages, Moderna and others are racing to develop an mRNA vaccine for the rare Bundibugyo virus driving the current ...

The companies will combine their complementary expertise in synthetic oligosaccharides, conjugation process development and GMP vaccine manufacturing to support partners developing next-generation con ...

ACT-CHIK, a project led by Institut Pasteur, will advance chikungunya vaccine trials across four African countries.

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

The vaccine development process and coordination between health organizations have improved since a devastating 2014-2016 ...

Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...

Leishmaniasis is present in approximately 200 countries worldwide, being a major public health problem primarily in the ...

The MVA platform is uniquely designed to incorporate multiple antigens into a single vaccine. This versatility allows GeoVax to develop vaccines targeting multiple aspects of a single pathogen or ...

SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and PreventionSK bioscience is jointly ...

Clinical trials for a hantavirus vaccine could take a decade or more without a massive federal push like Operation Warp Speed ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...